id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-333999-k92fmnq7	Yang, Chih-Jen	Remdesivir Use in the Coronavirus Disease 2019 Pandemic: A Mini-Review	2020-10-05		.txt	text/plain	2581	158	47	In this mini-review, we summarize the current evidence on the efficacy and challenges of remdesivir for the treatment of coronavirus disease 2019 (COVID-19). J o u r n a l P r e -p r o o f Based on several clinical trials and reports on its compassionate use, remdesivir is considered by many to be the most promising drug for the treatment of COVID-19 [44] [45] [46] . First, to evaluate the efficacy and safety of remdesivir in patients with COVID-19, a randomized, placebo-controlled, double-blind, multicenter, phase 3 clinical trial was launched on February 5, 2020, in China 30, 60 . Clinically, common adverse drug reactions (ADRs) noted during the compassionate use of remdesivir in patients with COVID-19 reported by Grein et al.	./cache/cord-333999-k92fmnq7.txt	./txt/cord-333999-k92fmnq7.txt